PortfoliosLab logoPortfoliosLab logo
AVA vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVA vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avista Corporation (AVA) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AVA achieves a 11.19% return, which is significantly higher than ABBV's -4.18% return. Over the past 10 years, AVA has underperformed ABBV with an annualized return of 4.23%, while ABBV has yielded a comparatively higher 17.47% annualized return.


AVA

1D
3.33%
1M
4.02%
YTD
11.19%
6M
8.65%
1Y
14.60%
3Y*
5.43%
5Y*
3.34%
10Y*
4.23%

ABBV

1D
1.16%
1M
4.26%
YTD
-4.18%
6M
-2.42%
1Y
18.95%
3Y*
20.56%
5Y*
18.28%
10Y*
17.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVA vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AVA
Avista Corporation
11.19%10.68%7.84%-15.31%8.79%10.27%-13.10%17.28%-15.07%32.87%
ABBV
AbbVie Inc.
-4.18%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between AVA and ABBV is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2013

0.23

Fundamentals

Market Cap

AVA:

$3.45B

ABBV:

$382.12B

EPS

AVA:

$2.53

ABBV:

$2.05

PE Ratio

AVA:

16.55

ABBV:

104.95

PS Ratio

AVA:

2.53

ABBV:

6.08

PB Ratio

AVA:

1.24

ABBV:

13.90

Total Revenue (TTM)

AVA:

$1.35B

ABBV:

$62.82B

Gross Profit (TTM)

AVA:

$711.00M

ABBV:

$46.15B

EBITDA (TTM)

AVA:

$455.00M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVA vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVA
AVA Risk / Return Rank: 6363
Overall Rank
AVA Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
AVA Sortino Ratio Rank: 5858
Sortino Ratio Rank
AVA Omega Ratio Rank: 5656
Omega Ratio Rank
AVA Calmar Ratio Rank: 6767
Calmar Ratio Rank
AVA Martin Ratio Rank: 6969
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6262
Overall Rank
ABBV Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 5959
Sortino Ratio Rank
ABBV Omega Ratio Rank: 5858
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6363
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVA vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avista Corporation (AVA) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AVAABBVDifference

Sharpe ratio

Return per unit of total volatility

0.83

0.79

+0.04

Sortino ratio

Return per unit of downside risk

1.21

1.25

-0.04

Omega ratio

Gain probability vs. loss probability

1.15

1.16

-0.01

Calmar ratio

Return relative to maximum drawdown

1.43

1.13

+0.30

Martin ratio

Return relative to average drawdown

3.62

2.54

+1.08

AVA vs. ABBV - Sharpe Ratio Comparison

The current AVA Sharpe Ratio is 0.83, which is comparable to the ABBV Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of AVA and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AVAABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.83

0.79

+0.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.16

0.80

-0.65

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.17

0.68

-0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

0.73

-0.43

Drawdowns

AVA vs. ABBV - Drawdown Comparison

The maximum AVA drawdown since its inception was -78.86%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AVA and ABBV.


Loading charts...

Drawdown Indicators


AVAABBVDifference

Max Drawdown

Largest peak-to-trough decline

-78.86%

-45.09%

-33.77%

Max Drawdown (1Y)

Largest decline over 1 year

-9.89%

-17.32%

+7.43%

Max Drawdown (3Y)

Largest decline over 3 years

-25.67%

-20.74%

-4.93%

Max Drawdown (5Y)

Largest decline over 5 years

-28.74%

-21.92%

-6.82%

Max Drawdown (10Y)

Largest decline over 10 years

-37.17%

-45.09%

+7.92%

Current Drawdown

Current decline from peak

-0.53%

-9.77%

+9.24%

Average Drawdown

Average peak-to-trough decline

-21.83%

-10.73%

-11.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.90%

7.67%

-3.77%

Volatility

AVA vs. ABBV - Volatility Comparison

Avista Corporation (AVA) and AbbVie Inc. (ABBV) have volatilities of 5.69% and 5.42%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AVAABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.69%

5.42%

+0.27%

Volatility (6M)

Calculated over the trailing 6-month period

13.43%

17.63%

-4.20%

Volatility (1Y)

Calculated over the trailing 1-year period

17.63%

23.95%

-6.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.54%

22.84%

-1.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.46%

25.74%

-0.28%

Dividends

AVA vs. ABBV - Dividend Comparison

AVA's dividend yield for the trailing twelve months is around 4.70%, more than ABBV's 3.13% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
3.13%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
AVA
Avista Corporation
4.70%5.09%5.19%5.15%3.97%3.98%4.04%3.22%3.51%2.78%3.43%3.73%

Financials

AVA vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Avista Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B202220232024202520260
15.00B
(AVA) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVA and ABBV have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AVA has higher volatility (5.69%) compared to ABBV (5.42%). In terms of maximum drawdown, AVA dropped -78.86% vs ABBV's -45.09%.

AVA currently has the higher Sharpe Ratio (0.83 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AVA and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer